HENWOOD GERALDINE 4
4 · Recro Pharma, Inc. · Filed Dec 9, 2020
Insider Transaction Report
Form 4
HENWOOD GERALDINE
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2020-12-05$2.30/sh−34,128$78,494→ 207,066 total
Holdings
- 50,000(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.